Publication:
Serum IL-17A in Behcet-s disease

Simple item page
dc.contributor.authorEmiroglu, NAZAN
dc.contributor.authorCengiz, FATMA PELİN
dc.contributor.authorERDEM, Gul Bahar
dc.contributor.institutionauthorEMİROĞLU, NAZAN
dc.contributor.institutionauthorCENGİZ, FATMA PELIN
dc.date.accessioned2020-10-29T14:39:28Z
dc.date.available2020-10-29T14:39:28Z
dc.date.issued2015-01-01T00:00:00Z
dc.description.abstractIntroduction: Behcet-s disease is a chronic multisystem disease with spontaneous remissions and relapses. Several studies show that autoimmune mechanisms play an important role in the development of Behcet-s disease. Activation of T cells and neutrophils is important in the pathogenesis of the disease. Interleukin 17 (IL-17) is a new cytokine that induces several types of cells to secrete proinflammatory cytokines in many inflammatory and autoimmune diseases.
dc.identifier.citationEmiroglu N., Cengiz F. P. , ERDEM G. B. , -Serum IL-17A in Behcet-s disease-, POSTEPY DERMATOLOGII I ALERGOLOGII, cilt.32, ss.358-361, 2015
dc.identifier.doi10.5114/pdia.2015.54745
dc.identifier.pubmed26759544
dc.identifier.scopus84946012432
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25359
dc.identifier.urihttps://www.termedia.pl/Serum-IL-17A-in-Behcet-s-disease,7,25937,0,1.html
dc.identifier.wosWOS:000365404500007
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBehcet-s disease
dc.titleSerum IL-17A in Behcet-s disease
dc.typeArticle
dspace.entity.typePublication
local.avesis.id27e9a351-786e-417f-80c2-929badeb0827
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublication59744f77-dd5d-4ff4-964f-0bb4780aaac6
relation.isAuthorOfPublication292e9ebe-735f-4346-90cf-5e0d8d0ed89d
relation.isAuthorOfPublication.latestForDiscovery292e9ebe-735f-4346-90cf-5e0d8d0ed89d

Files

Collections

Yayınlar - Eserler